Disclaimer

The Fullscript Integrative Medical Advisory team has developed or collected these protocols from practitioners and supplier partners to help health care practitioners make decisions when building treatment plans. By adding this protocol to your Fullscript template library, you understand and accept that the recommendations in the protocol are for initial guidance and may not be appropriate for every patient.

Upload this template

Th2 Modulation & Th1 Support Protocol (Right Loop)

Developed with Samuel F. Yanuck, D.C., FACFN, FIAMA+

Protocol Objective:

This protocol is intended for patients in need of support for both Th1 response and modulation of Th2 response. These patients typically have challenges related to hollow-space immunity, self-tissue response and mucosal tolerance. The products in this protocol are designed to support cytokine balance, mucosal health and Th1/Th2 balance.

Protocol:

Th2 Modulator

2 capsules, once to twice per day, with or between meals, minimum 3 months

Download the US product monograph

Th1 Support

2 capsules, once to twice per day, with or between meals, minimum 3 months

Download the US product monograph

Balanced Immune

1 capsule, once to twice per day, with or between meals, minimum 3 months

Download the US product monograph

Additional Support Products:

  • l-Glutamine
  • Liposomal Glutathione

Acute/Intensive Support for Self-tissue Response:

Consider increasing the dose of Balanced Immune, Th1 Support, and Th2 Modulator and/or introducing one or more of the following:

    • Liposomal Glutathione
    • Vitamin D3

 

When applying the PureResponseTM Immune Protocols, supplementation with Th1 Support will not be appropriate for a small subset of patients. This small subset is typically identified by a recent, vigorous onset of self-tissue response, most often associated with the need for joint support or joint comfort. Labs may indicate a need to modulate monocyte response (percentage). For these patients, supplementation with Balanced Immune may be indicated.

Duration:

The initial application of the PureResponseTM Immune Protocols is intended to be three to six months. After this period, product dosages may be lowered or discontinued if appropriate, based on patient status, Cogence Brief Immunological Assessment results, lab test results, and the clinician’s impression of the ongoing need for support.